Toth Financial Advisory’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Toth Financial Advisory’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-50	Closed	-$2K	–	451
2018 Q3	$2K	Buy	+50	New	+$1.9K	﹤0.01%	401

Other funds holding SBIO

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BFG

Bouchey Financial Group Troy, New York $1.55B AUM 29.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Toth Financial Advisory's SBIO Position: Q4 2018 in Review

Toth Financial Advisory sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2018, closing a stake of 50 shares — an estimated $2K sold.

Toth Financial Advisory first reported a position in SBIO in Q3 2018 and held it in 1 quarter. The position peaked at $2K in Q3 2018. 48 funds tracked by Wall St. Rank hold SBIO as of Q4 2018.

Toth Financial Advisory reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2018 after selling out during the quarter.
Toth Financial Advisory sold 50 ALPS Medical Breakthroughs ETF shares in Q4 2018, an estimated $2K.
Toth Financial Advisory first reported a position in ALPS Medical Breakthroughs ETF in Q3 2018 and held it in 1 quarter.
Toth Financial Advisory's ALPS Medical Breakthroughs ETF position peaked at $2K in Q3 2018.
48 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2018.

Based on Toth Financial Advisory's 13F filing for Q4 2018, filed 22 Jan 2019.